Ledger.Open graph →

SEC Form D · filed February 4, 2016

Kitov Pharmaceuticals Holdings Ltd

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

TEL AVIV, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

John Paul Waymack · Tel Aviv, L3Exec · Director Moran Sherf-Blau · Tel Aviv, L3Director Isaac Israel · Tel Aviv, L3Exec · Director Simcha Rock · Tel Aviv, L3Exec · Director Alain Zeitoun · Tel Aviv, L3Director Gil Ben-Menachem · Tel Aviv, L3Exec Philip Serlin · Tel Aviv, L3Director Ed Mock · Austin, TXExec · Director Ryan Wuerch · Austin, TXDirector Mike Lohner · Austin, TXDirector Paul C. Belden · Newport Beach, CAExec Jeff Lin · NEW YORK, NYExec · Director Daniel Weinberg · NEW YORK, NYExec · Director Laren B. Gillespie · Grand Cayman, Cayman IslandsExec · Director David B. Puritz · New York, NYExec · Director Leonard Schiller · Englewood, NJExec Kirk N. Nielsen · San Francisco, CADirector Robin N. Praeger · San Francisco, CADirector Thomas N. Woiwode · San Francisco, CAExec · Director Philip Serlin · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗